There's a scientific breakthrough in your medicine cabinet. But how did it get there?
At a time when medicines are helping us all live longer and healthier lives, this podcast will explore where these taken-for-granted miracles come from, how many of them almost never happened, where the life science ecosystem is taking us next, and most importantly, what it means for patients.
From chance meetings that led to new ideas, to risky investments that never pay off, hear from the people behind today's and tomorrow's treatments, vaccines, technologies, devices, and yes, cures.
In this golden age of health discovery and innovation fueled by record breaking investment in the life sciences, we'll bring guests who really understand what it means to be Making Medicine.
All content for Making Medicine is the property of Incubate Coalition and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
There's a scientific breakthrough in your medicine cabinet. But how did it get there?
At a time when medicines are helping us all live longer and healthier lives, this podcast will explore where these taken-for-granted miracles come from, how many of them almost never happened, where the life science ecosystem is taking us next, and most importantly, what it means for patients.
From chance meetings that led to new ideas, to risky investments that never pay off, hear from the people behind today's and tomorrow's treatments, vaccines, technologies, devices, and yes, cures.
In this golden age of health discovery and innovation fueled by record breaking investment in the life sciences, we'll bring guests who really understand what it means to be Making Medicine.
UK Pharma Challenges, DTC Ads Debate & 5 New FDA Approvals | Making Medicine
Making Medicine
10 minutes
1 month ago
UK Pharma Challenges, DTC Ads Debate & 5 New FDA Approvals | Making Medicine
This week, John Stanford dives into the UK’s pharmaceutical challenges, including ABPI’s warning about declining competitiveness and major companies pausing investment. We also explore the debate over direct-to-consumer drug advertising in the U.S. and how it ties into investment decisions and the pill penalty. Finally, we close with August’s FDA approvals, celebrating breakthroughs for rare diseases and cancer patients.
What do you think? Can the UK become Europe’s life sciences hub by 2030? Should the U.S. rethink DTC advertising, or does it play a vital role in innovation? Which of this month’s FDA approvals excites you most?
If you're new to the Making Medicine Podcast, we're happy you're here! Follow us for more: https://x.com/MakingMedPod https://www.instagram.com/makingmedicinepod/ https://www.linkedin.com/showcase/making-medicine-podcast/about/?viewAsMember=true
Timestamps: 0:00 Welcome to Making Medicine 0:28 UK pharma outlook and ABPI report 1:37 Weaknesses in UK drug investment 2:24 Companies pausing UK investments 3:08 U.S. vs UK drug access and pricing 4:08 Global pressure for fair drug pricing 4:33 MFN pricing concerns in the U.S. 5:09 Debate over drug advertising 6:09 How DTC ads affect biotech investment 7:26 Connection to the pill penalty 7:48 FDA Approvals Corner – August highlights 8:17 Jazz Pharmaceuticals – Modeyso approval 8:36 Boehringer Ingelheim – Hernexeos approval 9:17 Other rare disease drug approvals 10:23 Closing thoughts & FDA wins
DISCLAIMER: We’re reporting on the headlines, not making medical recommendations. For personal health questions, always consult a doctor.
Making Medicine
There's a scientific breakthrough in your medicine cabinet. But how did it get there?
At a time when medicines are helping us all live longer and healthier lives, this podcast will explore where these taken-for-granted miracles come from, how many of them almost never happened, where the life science ecosystem is taking us next, and most importantly, what it means for patients.
From chance meetings that led to new ideas, to risky investments that never pay off, hear from the people behind today's and tomorrow's treatments, vaccines, technologies, devices, and yes, cures.
In this golden age of health discovery and innovation fueled by record breaking investment in the life sciences, we'll bring guests who really understand what it means to be Making Medicine.
